# Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress.

> **NCT04780763** · NA · COMPLETED · sponsor: **Danone Global Research & Innovation Center** · enrollment: 168 (actual)

## Conditions studied

- Anxious Healthy Subjects

## Interventions

- **OTHER:** Milk product fermented by lactic bacteria or not fermented

## Key facts

- **NCT ID:** NCT04780763
- **Lead sponsor:** Danone Global Research & Innovation Center
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-04
- **Primary completion:** 2021-09-14
- **Final completion:** 2021-12-22
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2022-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04780763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04780763, "Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04780763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
